← Evidence map

ArticleCancer science2021

Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancer.

Yu Wakabayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33103296